Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
https://www.fda.gov/drugs/resources-information-approved-drugs/withdrawn-fda-grants-accelerated-approval-infigratinib-metastatic-cholangiocarcinoma#:~:text=On%20May%2028%2C%202021%2C%20the,2%20(FGFR2)%20fusion%20or%20other
01 Nov 2021
// Kyle LaHucik FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/lianbio-snags-325m-ipo-slightly-bigger-than-multi-partnered-biotech-s-2020-series-a
02 Dec 2020
// ENDPTS
https://endpts.com/bridgebio-grabs-a-second-priority-review-for-the-portfolio-giving-perceptive-startup-cause-to-celebrate/
01 Dec 2020
// GLOBENEWSWIRE
http://www.globenewswire.com/news-release/2020/12/01/2137349/0/en/BridgeBio-Pharma-and-Affiliate-QED-Therapeutics-Announce-FDA-Acceptance-of-New-Drug-Application-for-Infigratinib-for-the-Treatment-of-Cholangiocarcinoma.html
28 Jul 2020
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2020/07/28/2068546/0/en/Ivy-Brain-Tumor-Center-and-BridgeBio-Pharma-s-QED-Therapeutics-Announce-Dosing-of-First-Patient-in-Investigator-Initiated-Phase-0-2-Clinical-Trial-of-Infigratinib-in-Recurrent-Glio.html
ABOUT THIS PAGE